Drug profile · INN
trimethaphan camsylate
ARFONAD
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trimethaphan camsylate (ARFONAD) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN trimethaphan camsylate
Brand ARFONAD
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is trimethaphan camsylate?
trimethaphan camsylate (ARFONAD) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for trimethaphan camsylate?
ARFONAD is a marketed brand name for trimethaphan camsylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trimethaphan camsylate?
trimethaphan camsylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.